The global stem cell summit is concluded Relevant research in China has attracted much attention
The three-day 7th global stem cell summit concluded in pasadena, Los Angeles on Friday. More than 150 experts in various fields made on-site speeches and discussions, and over 1,000 experts in scientific research, medicine, business, law, education and ethics, as well as patient representatives attended the summit. China's stem cell research and related market conditions draw so much attention in the summit.
The summit is also announced as the "largest stem cell industry conference in North America". How to put relevant scientific research achievements in the stem cell field into use as soon as possible and truly serve patients become the real theme of this summit.
Stem-cell therapies face financial, policy and legal challenges some other series problems from laboratory research to actually serving patients. Bernie siegel, head of the institute of genetics policy and founder of the summit, told xinhua in an interview on Friday that the goal of the summit is to transform stem cell research in laboratories into treatments as soon as possible, it only can happen if there’s cooperation of various industries around the world.
Janet Loring, a professor of developmental neurobiology at the Scripps research institute, said the main point of the summit was to get researchers and mates from oy industries to build a network on stem cell-related issues. "So far, stem cell research has not been fully integrated into biomedical research, and that will change after the summit," she told reporters. At the summit, the ideas of experts in different fields can collide with each other. It is also the only meeting so far where I can consult lawyers and ethicists on stem-related issues.
China's stem cell research was one of the attentions at the summit. In stem cell research, China now has the largest number of published research papers other than the United States, and in stem cell research and related applications, all eyes should be on China's progress, siegel said.
Richard Gal, CEO of neuralstem, a stem cell research company that has cooperated with China many times, told xinhua that China's stem cell research is desirable and the Chinese stem cell market is promising.
- March 25, 2019Recently, in a research report published in the international magazine Stem Cell Reports, researchers from Boston University School of Medicine successfully used genetically modified embryonic stem ce...view
- July 23, 2018The CAR-T Congress gathers thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors. Discussing...view
- November 27, 2018Researcher Professor Chris Vakoc said that in this study we investigated the addictive behavior of the most aggressive cancer cells in the pancreatic cancer subtype, which has a very high mortality ra...view